Product Code: ETC6187625 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The parenteral nutrition market in Australia caters to patients who cannot receive adequate nutrients via the oral or enteral route. Hospitals and home care settings are major demand centers, especially for patients recovering from surgery or suffering from gastrointestinal disorders. Increased awareness among healthcare professionals about malnutrition management and advancements in IV nutrition formulations are propelling market demand. Regulatory compliance and patient safety are key concerns, and the governments focus on improving critical care services contributes to the growth of this segment.
Australias parenteral nutrition market is seeing growth driven by advancements in clinical nutrition, aging demographics, and rising hospital admissions for chronic illnesses. Healthcare facilities are increasingly using tailored parenteral nutrition therapies for patients who cannot absorb nutrients orally. Innovations in nutrient formulations and packaging, such as multi-chamber bags and reduced contamination risk systems, are gaining traction. The shift towards home-based care is also opening up new growth avenues.
The parenteral nutrition market in Australia faces significant hurdles due to the complexity of formulations, high costs, and strict regulatory requirements. These intravenous nutrition solutions require sterile production environments and adherence to specific nutrient compositions tailored to individual patient needs. Supply chain disruptions, especially in sourcing key nutrients or ingredients, can cause shortages. Moreover, the need for trained professionals to administer and monitor parenteral nutrition restricts its use to hospitals and specialized care centers.
Parenteral nutrition in Australia offers investment opportunities in both hospital-based services and home-based care. Manufacturers of sterile nutrition bags and related infusion equipment could find a strong foothold in the domestic market. There`s also room for investment in compounding facilities that prepare customized parenteral solutions. Furthermore, telehealth support and mobile nursing services for patients requiring long-term parenteral nutrition represent a promising area of expansion.
The parenteral nutrition market in Australia is influenced by government policies related to healthcare funding and medical device regulation. Parenteral nutrition is primarily used in hospital settings, and its accessibility is largely determined by Medicare policies. The Australian government reimburses hospitals for the use of parenteral nutrition, but reimbursement rates and eligibility criteria can vary depending on the type of treatment and patient need. The Therapeutic Goods Administration (TGA) regulates the approval of intravenous nutrition solutions, ensuring that products meet stringent safety standards. However, as the population ages and the demand for specialized care rises, funding constraints in public healthcare systems pose ongoing challenges for the broader availability of parenteral nutrition therapies.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Australia Parenteral Nutrition Market Overview |
3.1 Australia Country Macro Economic Indicators |
3.2 Australia Parenteral Nutrition Market Revenues & Volume, 2021 & 2031F |
3.3 Australia Parenteral Nutrition Market - Industry Life Cycle |
3.4 Australia Parenteral Nutrition Market - Porter's Five Forces |
3.5 Australia Parenteral Nutrition Market Revenues & Volume Share, By Nutrient Type, 2021 & 2031F |
3.6 Australia Parenteral Nutrition Market Revenues & Volume Share, By Dosage Form, 2021 & 2031F |
4 Australia Parenteral Nutrition Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases requiring parenteral nutrition support |
4.2.2 Growing geriatric population in Australia |
4.2.3 Technological advancements in parenteral nutrition formulations and delivery systems |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for parenteral nutrition products |
4.3.2 High cost associated with parenteral nutrition therapy |
4.3.3 Limited awareness about the benefits of parenteral nutrition among patients and healthcare providers |
5 Australia Parenteral Nutrition Market Trends |
6 Australia Parenteral Nutrition Market, By Types |
6.1 Australia Parenteral Nutrition Market, By Nutrient Type |
6.1.1 Overview and Analysis |
6.1.2 Australia Parenteral Nutrition Market Revenues & Volume, By Nutrient Type, 2021- 2031F |
6.1.3 Australia Parenteral Nutrition Market Revenues & Volume, By Carbohydrate, 2021- 2031F |
6.1.4 Australia Parenteral Nutrition Market Revenues & Volume, By Parenteral Lipid Emulsions, 2021- 2031F |
6.1.5 Australia Parenteral Nutrition Market Revenues & Volume, By Single Dose Amino Acid Solutions, 2021- 2031F |
6.1.6 Australia Parenteral Nutrition Market Revenues & Volume, By Trace Elements, 2021- 2031F |
6.1.7 Australia Parenteral Nutrition Market Revenues & Volume, By Vitamins and Minerals, 2021- 2031F |
6.2 Australia Parenteral Nutrition Market, By Dosage Form |
6.2.1 Overview and Analysis |
6.2.2 Australia Parenteral Nutrition Market Revenues & Volume, By Vials, 2021- 2031F |
6.2.3 Australia Parenteral Nutrition Market Revenues & Volume, By Ampoules, 2021- 2031F |
6.2.4 Australia Parenteral Nutrition Market Revenues & Volume, By Bottles, 2021- 2031F |
6.2.5 Australia Parenteral Nutrition Market Revenues & Volume, By Bags, 2021- 2031F |
7 Australia Parenteral Nutrition Market Import-Export Trade Statistics |
7.1 Australia Parenteral Nutrition Market Export to Major Countries |
7.2 Australia Parenteral Nutrition Market Imports from Major Countries |
8 Australia Parenteral Nutrition Market Key Performance Indicators |
8.1 Rate of adoption of advanced parenteral nutrition formulations |
8.2 Number of clinical trials and research studies on parenteral nutrition in Australia |
8.3 Patient satisfaction and outcomes improvement rates related to parenteral nutrition therapy |
9 Australia Parenteral Nutrition Market - Opportunity Assessment |
9.1 Australia Parenteral Nutrition Market Opportunity Assessment, By Nutrient Type, 2021 & 2031F |
9.2 Australia Parenteral Nutrition Market Opportunity Assessment, By Dosage Form, 2021 & 2031F |
10 Australia Parenteral Nutrition Market - Competitive Landscape |
10.1 Australia Parenteral Nutrition Market Revenue Share, By Companies, 2024 |
10.2 Australia Parenteral Nutrition Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |